OMX30 1 553 -0,1%  OMXH25 4 064 -0,4%  Bitcoin 6 508,28 -0,4%  Dow 25 798 2,2%  Nas 7 276 2,9%  EUR 10,3170 0,0%  USD 8,9419 0,3%  Olja 80,7 -1,0%  Guld 1 225 0,1% 

Sirtex Medical Aktie

<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
Obligationer
>

Nyheter om Sirtex Medical LtdShs

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om Sirtex Medical LtdShs

ytterligare analyser

Sirtex Medical Peer Group

Sirtex Medical 0,00
0,0%
pagehit

Lägg till instrument

Vad tycker du?

Profil Sirtex Medical LtdShstill bolagsprofilen

Sirtex Medical Ltd. engages in the research, commercial development, manufacture, and distribution of liver cancer treatments. It offers targeted radiation therapy known as SIR-Spheres Y-90 resin microspheres. Its clinical programs include SIRFLOX, FOXFIRE/FOXFIRE Global, SARAH, SIRveNIB, and SORAMIC. It operates through the following segments: Asia Pacific; Americas; and Europe, Middle East, and Africa. The company was founded in 1997 and is headquartered in North Sydney, Australia.

Till aktien Sirtex Medical

Ticker
ISIN AU000000SRX1
Index Australia All Ordinaries

Sirtex Medical Nyckeltal

Börsvärde i SEK 10,54 Mrd
Free float %
Antal aktier mio. 56,44
Cashflow/aktie i lokal valuta
Bokvärde/aktie i lokal valuta
60 dagar vola
PBV